SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-19-000534
Filing Date
2019-01-24
Accepted
2019-01-24 17:30:46
Documents
1
Period of Report
2019-01-24
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K a8k-reditrexpdufa.htm 8-K 22947
  Complete submission text file 0001628280-19-000534.txt   23950
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

IRS No.: 000000000
Type: 8-K | Act: 34 | File No.: 001-33637 | Film No.: 19540724
SIC: 2834 Pharmaceutical Preparations